Perigord | Life Science Artwork Solutions


Perigord is the global leader in the provision of high quality artwork and labelling outsource services and management solutions to the Life Science industries.

Proud Finalists of The Supplier of the Year 2018

Wednesday, September 12, 2018

We are proud to be selected as finalists for the 2018 “Supplier of the Year” award at the Irish Pharma Awards on the 23rd October at the Clayton Hotel Burlington Road, Dublin. Perigord has been supporting Irish Pharma companies and Global Pharma companies based in Ireland for over 10 years.

This award recognises the outstanding support we provide to all our clients in Ireland and globally, but above all acknowledges the contribution and hard work of all our global staff who thrive on delivering the highest levels of compliance and client service to our clients.

Perigord has been and continues to be a leading supplier of consultancy and labelling artwork solutions to the pharma industry worldwide. We work with our clients on everything from setting up their artwork processes, supplying expert resources to product launches and maintaining packaging compliance requirements.

Perigord plays a key role in ensuring all pharma product packaging complies with country regulations locally and globally and provides artwork solutions to 15 of the world’s leading top 20 pharmaceutical companies.

We pride ourselves on ensuring our client’s labelling artwork management needs are always met on time, every time and through regular monitoring, we ensure the highest level of quality and compliance are constantly maintained.

With more than 10 years of experience in the Life Science Industry, Perigord reduces the risk of product recalls caused by packaging and labelling non-compliance – ensuring Ireland’s key export sector keeps growing for years to come.

Perigord launches expanded 3D Modelling, Animation and Rendering Services

Tuesday, April 03, 2018

Perigord, providers of industry leading artwork and labeling solutions to Life Science companies are excited to announce their new cost-effective, high quality and compliant 3D Artwork Services. Our new 3D offering has garnered great feedback from our pharma clients. Delivered with the same commitment to quality and dedication to meeting our clients targets, Perigord's 3D services can become the centerpiece of your next marketing campaign. 

Perigord's 3D Services offers extends beyond standard still images to fully animated video, complete device renders and even 360° rotating PDFs.  Get full previews of all Perigord's 3D Services on this page

Perigord shortlisted for Supplier of the Year Award at Irish Pharma Awards

Thursday, September 21, 2017

Perigord are proud to announce that we have been shortlisted by the Irish Pharma Awards for Supplier of the Year. Since 2014, the Irish Pharma Awards have acted as a barometer of success for any organization in the Irish pharmaceutical and life sciences sector. The event is set to be attended by over 500 key pharma companies and influential industry thought leaders. 22 awards will be handed out on the night at the Clayton Hotel, Burlington Road, Dublin 4.

Perigord’s deep industry expertise and life sciences knowledge combined with our dedication to complete client satisfaction make us the leading choice for both artwork services and artwork management. Through GLAMS, Perigord offers the only Artwork Management System that is built from the ground up with the life sciences in mind. GLAMS enables pharma companies to better manage costs, ensure speed to market and maintain the highest possible quality levels throughout the artwork lifecycle.

Our nomination at the Irish Pharma Awards reflects our commitment to our clients in the life sciences sector by providing them with solutions and support that are designed and delivered with their exact needs in mind. In such a heavily regulated sector, it’s essential that suppliers are just as knowledgeable about standards and best practice as their clients" said Suzanne Ivory, Global Head of Quality

At Perigord, we pride ourselves in doing just that, giving our clients total peace of mind. We look forward to attending on the night and wish all fellow nominees the best of luck” she concluded

We look forward to meeting our clients and colleagues at the gala event on Thursday, October 5th and seeing what the night has in store for Perigord. Before that, you can request a GLAMS Demo today and learn how it can grant you total control over your artwork process. 

Perigord adds €3m in funding to continue GLAMS success

Thursday, August 10, 2017

Investment will be used to facilitate rapid international growth of their software product, GLAMS (Global Artwork Management System)

Dublin, Ireland, August 10th, 2017. Perigord, a Dublin based company specialised in artwork solutions for the pharma and life science industries, recorded 100% growth last year in its software division. In 2017, the company is on track to exceed this figure and the BDO Development Capital Fund supports this growth with an investment of €3 million. This will bring the total investment to €5.4 million, since the first input made by the Fund in February 2016.

With two complementary divisions and a global office network in Europe, USA and Asia, Perigord will use the investment to facilitate international growth of their software product, GLAMS (Global Artwork Management System), as well as continue their supply of precision global artwork services to pharmaceutical and life science companies worldwide.

Alan Leamy, CEO of Perigord, has ambitious plans for scaling the business and the recent investment will help the company to realise these goals. Perigord’s latest software is setting the global standard for management of artwork in the heavily regulated pharma and life science sectors.

Perigord currently have over 250 staff worldwide with centres in Europe, Asia and the USA, and their customer base has expanded to include nine of the world's top ten pharmaceutical companies.

Alan Leamy commented on the recent investment: “BDO Development Capital Fund’s investment has presented the company with a great opportunity to grow on a global scale. It will allow Perigord to service the rapidly expanding life sciences sector as it goes through significant changes and growth in the coming 5-year period. With this investment and the recent upsurge in demand for the product, Perigord are poised to unlock this growth and position itself as the dominant player in this heavily regulated sector.”

Sinead Heaney, Investment Director at the BDO Development Capital Fund, is delighted to be supporting Perigord at such a pivotal time: “The BDO Development Capital Fund supports businesses which demonstrate the ambition, capability and strategy to deliver global expansion and achieve market leading positions. This follow-on investment demonstrates how much potential we see for Perigord moving forward. They have the ambition, capability and strategy to become a leading player in this sector”.

Perigord employees participated in the ‘Bray 10KM Cliff Run’

Thursday, April 13, 2017

On Saturday, April 1st, Perigord employees participated in the 'Bray 10KM Cliff Run'. This outdoor activity started in Greystones, and took us across the breath-taking cliff route to Bray.

Some weeks before the event, we had an informative and practical session offered by personal trainer Aaron Horan, who shared his experience and best practices to help us in our preparation.

The run was a huge success, and not only a wonderful opportunity to strengthen our team spirit and bring back more positive energy to our office, but a chance to raise funds that will be donated to a preferred charity at the end of this year. Perigord is known for organising different activities throughout the year to raise fund for charities.

Big thank you to all who took part in making 'Bray 10KM Cliff Run' another successful day out for Perigord! We are very proud of your achievement!

Perigord Sponsored Pharma Labeling Compliance Conference in Boston

Tuesday, April 04, 2017

Perigord sponsored and attended the '5th Annual Pharma Labeling Compliance Conference' on March 29-30, 2017 in Boston, USA.

This important event brought together pharma industry thought-leaders and specialists from companies across the globe to explore the emerging challenges and regulatory trends through presentations, discussions and networking. This year, the key topics of the conference were:

  • Developing an agile and actionable labelling strategy to prepare for the regulatory changes and the evolving industry requirements.
  • Creating a robust end-to-end tracking system to centralise labelling.
  • Comparing and contrasting pharma and medical device labelling to maximise efficiency across industries.
  • Incorporating human factor data in the label to improve product literacy.

We are very proud of our Global Quality Director; Suzanne Ivory, who presented and shared her expert knowledge on solutions to optimise end-to-end artwork processes. As the challenge to provide adequate artwork becomes more complex and the need for artwork management systems becomes more critical, we believe that sharing our expertise will help pharmaceutical labelling leaders to find innovative solutions to these challenges.

This has been another successful year for the 'Annual Pharma Labeling Compliance Conference' and we are already looking forward to next year!

Perigord Acquires Pharma International

Thursday, December 01, 2016

Perigord Acquires Pharma International

  • Positions for rapid growth in North and South America
  • Expands services to better serve its labeling artwork customers in the life science sector 
  • CEO of Pharma International will join Perigord in executive capacity as part of our Global Leadership Team 
  • Combined number of pharma/medical device customers grows to 30, ranging from emerging and midsized companies to the world’s largest  

Dublin, Ireland, and Syracuse, New York, December 1st, 2016 - Perigord today announced it has acquired Pharma International, Inc. (“PII”), for an undisclosed amount and effective immediately.  All employees of PII will join Perigord, with the combination expected to deliver the most robust menu of labeling and labeling-related services available in the industry.  Currently serving customers ranging from emerging pharma companies launching their first product to the largest pharma companies in the world, the goal of the expanded business is to continue to grow with the customers and to increase the number of customers served.

Perigord has expanded rapidly over the past several years, with operations in Europe, Asia, North America, and near-term plans to broaden into South America. The company is a global leader in delivery of best-in-class labeling artwork to life science companies, combined with GLAMS, a functionally robust, 21-CFR compliant, cloud-based, artwork management system. 

PII specializes in design, translation, medical illustration, and content development for life science company labeling and web initiatives. The company develops labeling-related materials including Instructions for Use, Starter Kits, Marketing PIs, and patient and provider education tools. Also, the company creates customer-specific style guidelines and right-first-time audit documents that improve consistency across company and product branding. Many PII customers are now in their second decade of relationship with the company and the company has won many of the industry’s major design awards.

The combined Perigord/PII team will collaborate to bring a new standard of accuracy, speed, consistency, compliance, and control to the development and management of a labeling library for its life science customers. “This is a coming together of two companies who share the same commitment to quality, and dedication to the life science sector,” said Perigord CEO Alan Leamy. “We look forward to bringing our global footprint, platform and technology to PII customers and we look forward to the expanded menu of services this merger brings to Perigord customers.” 

Perigord dramatically expands our capacity and presents an opportunity for PII to globalize our services overnight,” said PII CEO Gary Schueler. “Our life science customer base is largely North America. We look forward to offering expanded services to our US customers and partnering with Perigord to offer our services to their customers across the globe.” 

Perigord contact:  Mark Ennis, Global Business Development Director 
+ 353 1 4403 222 

Pharma International contact:  Orna Bresler, VP of Account Services 
+1 315.472.3998 x 236 

Perigord partners with GlobalVision to integrate artwork management solutions.

Wednesday, September 07, 2016

Perigord partners with GlobalVision to integrate artwork management solutions.

Dublin, Ireland, September 7, 2016.

Perigord, innovators in Life Science Artwork Management Services and Solutions, and GlobalVision, leaders in the design and delivery of Innovative Proofreading Technologies, today announced their alliance for the integration of their artwork management systems in order to better service the Life Science Industries.

Perigord, recognising the value of working with GlobalVision, who have over 25 years’ experience in proofreading, has entered this strategic collaboration to enable seamless integration of GlobalVision’s Proofware software into their GLAMS (Global Artwork Management System) solution, resulting in streamlined exchanges and decreased time to market in the artwork processes.

Perigord’s GLAMS is a Configurable Off the Shelf (COTS) solution for Artwork Management that meets the current and future needs of Life Science customers.  GlobalVision’s Proofware brings an advanced suite of application tools focused on delivering accuracy and traceability for Quality Control, reducing artwork rework cycles and cost. Through the integration of these software management systems, the user will benefit from quicker file comparisons during proofreading, improved quality control and earlier error detection.  In addition, both systems facilitate 21 CFR Part 11 compliance to electronic records and electronic signature rules.

"We are excited to team with GlobalVision as they, like us, are specialists in the Life Science Industries and understand the GMP environment”, says Alan Leamy, CEO Perigord.  “As one of our new partners, GlobalVision represent our belief that the future of artwork management through the lifecycle process requires integrated automated technologies as a necessity of providing accurate artwork to market, on time and right first time.”

Jonathan Hou, Director of Technology at GlobalVision, also comments: “At GlobalVision, we are looking forward to the synergy this strategic partnership can bring to current and future clients, and we recognize that Perigord’s business mission fits very well with that of our Life Science focus.”

About Perigord

Perigord are specialists in the provision of artwork and labelling outsource services and management solutions to the Life Science Industries globally. Perigord’s unique combination of offerings and technical expertise, coupled with our ability to continually deliver Right First Time artwork, offers the Life Science Industries the perfect solution for outsourced artwork production.

Perigord’s flagship software product GLAMS (Global Artwork Management Software) is a web-based Life Science Artwork Management Solution, developed and designed to control and manage artwork through the artwork lifecycle. 


Mark Ennis

Contact Us

About GlobalVision

GlobalVision is the world leader in the design of innovative proofreading technologies. With over 25 years of experience, we've helped customers increase proofreading accuracy, efficiency, and speed. Our solutions have been integrated into the packaging workflows of leading consumer packaged goods companies, printing firms and over 70% of the top pharmaceutical companies worldwide.


Michael Malz

Contact GlobalVision

Perigord enters new Strategic Partnership with Nathean

Tuesday, June 21, 2016

Perigord partners with Nathean to provide Life Science Artwork Management Software customers with increased levels of performance and superior data-driven decisions.

Dublin, Ireland, 21 June 2016.

Perigord, the global leader in Life Science artwork management services and solutions, recently entered a strategic partnership with data analytics and reporting company Nathean to provide Logix, their Business Intelligence and enhanced KPI Reporting tool, as an integrated feature within Perigord’s Global Artwork Management System (GLAMS).

Life Science companies are constantly facing challenges with the agile and secure management of digital artwork assets and this has become a key strategic focus following the recent increase in mergers and acquisitions.

The partnership between Perigord and Nathean offers Life Science artwork management software customers actionable analytics, granting the capture of extensive amounts of information in easy to view dashboards, tailored views and automated email reports, previously unseen as part of an artwork management software solution.

Speaking of the partnership, Perigord’s Head of Professional Services, Sam Cole says “Perigord are very pleased to work with Nathean to provide informed decision making and planning through our GLAMS Analytics tool.  The Business Intelligence and enhanced KPI Reporting feature provides configurable reporting dashboards enabling faster analysis and reporting, offering GLAMS customers the benefits of deeper and richer business insights. A system such as this which presents visibility and reporting of live artwork data is exactly what our customers have been requesting and we are delighted to now be in a position to offer this as part of our GLAMS offering.”

Maurice Lynch, CEO of Nathean, also comments on the co-operation between Perigord and Nathean noting “Working with a well-established global Life Science partner such as Perigord allows Nathean the opportunity to assist their GLAMS customers by offering an increased return on investment.  By implementing the Business Intelligence and enhanced KPI Reporting feature, GLAMS customers are allowed autonomous and uniformed decision making for all users.”

About Perigord

Perigord are specialists in the provision of artwork and labelling outsource services and management solutions to the Life Science Industries globally. Perigord’s unique combination of offerings and technical expertise, coupled with our ability to continually deliver Right First Time artwork, offers the Life Science Industries the perfect solution for outsourced artwork production.

Perigord’s flagship software product GLAMS (Global Artwork Management Software) is a web-based Life Science Artwork Management Solution, developed and designed to control and manage artwork through the artwork lifecycle. 


Barbara Murphy

Marketing Manager

Contact Us

About Nathean

Nathean develops Logix, a ground breaking self-service Analytics & Reporting platform designed to effortlessly connect people and information. Every day Logix enables people to discover actionable insights from data helping drive better business outcomes.


Maurice Lynch


Contact Nathean

Perigord explains the importance of compliant, validated artwork and labelling solutions in the pharmaceutical sector

Tuesday, April 12, 2016

The number of pharmaceutical product recalls are growing. Some estimates show that over 50% of recalls are related to pharmaceutical packaging artwork and labelling.

How many times have we heard these statistics over the last 20 years? And yet nothing changes.

The bottom line is that if there is an error with pharmaceutical artwork, the patient can die. The absence of regulatory requirements within the pharmaceutical industry regarding the production of artwork is indicative of the lack of focus often given to this process.

There is increased pressure to improve operational performances and reduce the level of human error. If we make it easy for someone to make a mistake, they will. We need to make it easy to get it right first time.

To do this we have to take a realistic look at the challenges faced by the pharmaceutical industry over the next five to ten years which will impact the artwork process and determine what robust innovative measures we should take to ensure these recall figures don’t spiral out of control.

Attitudes towards artwork management within the supply chain need to change. There should be a focus on quality driven systems to enable continuous technological developments facilitate the automation and standardisation required to prevent mistakes.

Industry analysis

Firstly we need to look at some of the key aspects of the pharmaceutical industry that are driving change.

1. Mergers & Acquisitions in the healthcare sector set a new record in 2015 of $724 billion. As a result, the agile and secure management of digital artwork assets has become a key strategic focus. 

2. Serialisation will result in a combination of more artwork content and stricter directives governing readability. This combined with reduced print space will drive an unprecedented demand for regulated artwork services and management systems over the next 5 years. 

3. Product proliferation leads to significantly increased frequency of artworking events and far greater complexities in managing the artworking processes with many companies having reached or exceeded their capability to manage the process internally. 

4. As a result of the patent cliff, a single innovative pharmaceutical product which has lost patent protection is being replaced with new generic products globally, leading to an exponential growth in demand for outsourced artwork solutions. 

What needs to be done?

Why do we accept high levels of inaccuracy when we can standardise how artwork is created and automate how it’s managed?

Pharmaceutical companies need to understand how their present artwork processes should change to facilitate these future drivers. To navigate accurately through these changes a proactive and systematic approach to artwork is crucial. Companies have to ask themselves if the artwork process is clearly defined, optimised and quality driven.

Managing artwork for the pharmaceutical industry is a very specialised, niche service which can only be properly controlled by a GMP compliant partner. If using a vendor, it is critical to develop a partnership to ensure all aspects of the artwork supply chain are controlled and agile to meet the challenges of the industry.

The two fundamental areas which need to be addressed are the physical production of the artwork and the management of the artwork process.

Artwork production 

Perigord recommends a one touch process in building compliant artwork which increases efficiency, reduces costs and minimises risk through fewer stages, thus eliminating the historical prepress stage. Effectively this means that artwork is built to high quality standards (and print ready) and the layer structure and font integrity is maintained throughout the approval cycle. Perigord ensures this process sits in a robust quality management system with a change management procedure that facilitates the efficiencies to be gained through the introduction of automated technology. 

Artwork management systems 

The most obvious way to remove the dangers of human error is to automate. Managing the amount of stakeholders and the input they have in this complex process by email is inconsistent with every company’s objective of getting product to market on time and right first time. This needs to be replaced by a highly configurable system that can be easily adapted to align with a customer's current and future processes, giving the flexibility of a systematic approach to managing products and product related information. 

In summary, reducing the number of recalls in the pharmaceutical industry requires better regulation, improved operational procedures and a change of attitude towards artwork production and management. The challenges that lie ahead have been identified, all we need now is to face them head on, in a controlled GMP fashion.


1 -

2 - 

Recent Posts



Centralised Global QMS Certified to ISO 9001:2015 & PS 9000:2016